Cargando…
The prognostic value of NRF2 in solid tumor patients: a meta-analysis
Nuclear factor E2-related factor 2 (NRF2), a transcription factor, is known as a potential therapeutic target of solid tumor for that it is a master regulator of the injury and inflammation response, including controlling antioxidant cell progress. Recent studies showed that NRF2 played significant...
Autores principales: | Wang, Lingling, Zhang, Chunze, Qin, Litao, Xu, Jingyue, Li, Xiaobo, Wang, Wenhong, Kong, Lingqin, Zhou, Taizhen, Li, Xichuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787436/ https://www.ncbi.nlm.nih.gov/pubmed/29416692 http://dx.doi.org/10.18632/oncotarget.19838 |
Ejemplares similares
-
The prognostic value of p62 in solid tumor patients: a meta-analysis
por: Ruan, Haihua, et al.
Publicado: (2017) -
Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis
por: Ruan, Haihua, et al.
Publicado: (2017) -
Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors
por: Song, Wei, et al.
Publicado: (2017) -
Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis
por: Zhang, Xianyun, et al.
Publicado: (2017) -
Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients
por: Yang, Yong, et al.
Publicado: (2017)